CytomX Therapeutics Added to NASDAQ Biotechnology Index
Dec 18, 2017 13:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Dec. 18, 2017 -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today...
Samumed Doses First Patient in Phase 1 Trial of SM04690 for Treatment of Degenerative Disc Disease
Dec 18, 2017 13:00 pm UTC| Business
SAN DIEGO, Dec. 18, 2017 -- Samumed, LLC, today announced the dosing of the first degenerative disc disease (DDD) patient in its Phase 1 trial of SM04690, a small molecule Wnt pathway inhibitor formulated as an...
Dec 18, 2017 13:00 pm UTC| Business
REDWOOD CITY, Calif., Dec. 18, 2017 -- A recently published report, Dell’Oro Group, the trusted source for market information about the telecommunications, networks, and data center IT industries, shows that virtual...
Dec 18, 2017 13:00 pm UTC| Business
HORSHAM, Pa., Dec. 18, 2017 -- Phenom People, the leader in Talent Relationship Marketing, announced its latest product release designed to make the internal mobility and referral application process easier and more...
Cyber Security Market Worth $181.77 Billion by 2021: Zion Market Research
Dec 18, 2017 12:55 pm UTC| Business
Sarasota, FL, Dec. 18, 2017 -- Zion Market Research has published a new report titled “Cyber Security Market (Network Security, Cloud Security, Wireless Security, and Others), By Solution (Identity and Access Management...
Arch Therapeutics Withdraws 510(k) with Plans to Resubmit After Further Discussions with FDA
Dec 18, 2017 12:50 pm UTC| Business
FRAMINGHAM, Mass., Dec. 18, 2017 -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, today announced that the Company has...
Dec 18, 2017 12:45 pm UTC| Business
NEW YORK, Dec. 18, 2017 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Verso Corporation...